Delivery Order SPE2DB22D2007-SPE2DB23FJ2HF
- Not listed
- This federal contract award, valued at $14,625.76, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with an ultimate completion date of April 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,252.25 contract provides the DLA with deliveries of SHINGRIX vial kits, a vaccine product. The award is a firm fixed-price delivery order and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key supplier to various government agencies, particularly the Department...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,003.00 firm fixed-price delivery order is for "SHINGRIX VIAL KITS" and has a completion date of January 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of the parent company Cencora, Inc. The contract is a delivery order valued at $1,069.01 for the provision of SHINGRIX VIAL KITS, a vaccine product. The contract has an ultimate completion date of September 11, 2023 and utilizes a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of SHINGRIX vaccine kits to the Defense Logistics Agency (DLA), an agency of the Department of Defense. The $36,146.40 firm-fixed-price delivery order was issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides $9,501.50 for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA). The contract, a delivery order with a firm fixed price, has an ultimate completion date of February 14, 2022 and was awarded on February 11, 2022. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,069.01 for the supply of SHINGRIX vial kits. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 18, 2023. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $13,404.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX VIAL KITS, a medical product, with an ultimate completion date of April 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the contract is structured as a Delivery Order under a larger Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $1,806.56 for the supply of SHINGRIX vial kits. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a period of performance through April 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $12,736.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the provision of SHINGRIX VIAL KITS. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ2HFDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22D2007|SPE2DB23FJ2HF) valued at $21,945.86 for the supply of SHINGRIX VIAL KITS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 11, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This delivery order is likely part of the company's larger government contract portfolio with the DLA. The contract award does not indicate any set-aside designation, suggesting it was competed openly.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.9k | 5/10/23 |